{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:18:31Z","timestamp":1791389911090,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1038\/ncprheum1018","type":"journal-article","created":{"date-parts":[[2009,3,2]],"date-time":"2009-03-02T10:55:28Z","timestamp":1235991328000},"page":"139-148","source":"Crossref","is-referenced-by-count":70,"title":["Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside"],"prefix":"10.1038","volume":"5","author":[{"given":"Jill P","family":"Buyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncprheum1018_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/clin.1996.0018","volume":"78","author":"JP Buyon","year":"1996","unstructured":"Buyon JP et al. (1996) The effects of pregnancy on autoimmune diseases. Clin Immunol Immunopath 78: 99\u2013104","journal-title":"Clin Immunol Immunopath"},{"key":"BFncprheum1018_CR2","first-page":"1058","volume-title":"Dubois' Lupus Erythematosus","author":"JP Buyon","year":"2006","unstructured":"Buyon JP and Clancy RM (2006) Neonatal lupus. In Dubois' Lupus Erythematosus, edn 7, 1058\u20131080 (Eds Wallace DJ and Hahn BH) Philadelphia: Lippincott Williams & Wilkins"},{"key":"BFncprheum1018_CR3","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.4049\/jimmunol.157.8.3317","volume":"157","author":"JL Leach","year":"1996","unstructured":"Leach JL et al. (1996) Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol 157: 3317\u20133322","journal-title":"J Immunol"},{"key":"BFncprheum1018_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0735-1097(01)01697-7","volume":"39","author":"ET Jaeggi","year":"2002","unstructured":"Jaeggi ET et al. (2002) Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. J Am Coll Cardiol 39: 130\u2013137","journal-title":"J Am Coll Cardiol"},{"key":"BFncprheum1018_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","volume":"37","author":"JP Moak","year":"2001","unstructured":"Moak JP et al. (2001) Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 37: 238\u2013242","journal-title":"J Am Coll Cardiol"},{"key":"BFncprheum1018_CR6","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","volume":"31","author":"JP Buyon","year":"1998","unstructured":"Buyon JP et al. (1998) Autoimmune-associated congenital heart block: mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31: 1658\u20131666","journal-title":"J Am Coll Cardiol"},{"key":"BFncprheum1018_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.7326\/0003-4819-120-7-199404010-00003","volume":"120","author":"J Waltuck","year":"1994","unstructured":"Waltuck J and Buyon J (1994) Autoantibody-associated congenital heart block: outcome in mothers and children. Annals Int Med 120: 544\u2013551","journal-title":"Annals Int Med"},{"key":"BFncprheum1018_CR8","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","volume":"44","author":"A Brucato","year":"2001","unstructured":"Brucato A et al. (2001) Risk of congenital heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis. Arthritis Rheum 44: 1832\u20131835","journal-title":"Arthritis Rheum"},{"key":"BFncprheum1018_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","volume":"117","author":"DM Friedman","year":"2008","unstructured":"Friedman DM et al. (2008) Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 117: 485\u2013493","journal-title":"Circulation"},{"key":"BFncprheum1018_CR10","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/art.10232","volume":"46","author":"S Salomonsson","year":"2002","unstructured":"Salomonsson S et al. (2002) A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 46: 1233\u20131241","journal-title":"Arthritis Rheum"},{"key":"BFncprheum1018_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1084\/jem.20041859","volume":"201","author":"S Salomonsson","year":"2005","unstructured":"Salomonsson S et al. (2005) Ro\/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 201: 11\u201317","journal-title":"J Exp Med"},{"key":"BFncprheum1018_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4049\/jimmunol.152.7.3675","volume":"152","author":"JP Buyon","year":"1994","unstructured":"Buyon JP et al. (1994) Autoantibody responses to the \u201cnative\u201d 52 kDa SS-A\/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus and Sj\u00f6gren's syndrome. J Immunology 152: 75\u201384","journal-title":"J Immunology"},{"key":"BFncprheum1018_CR13","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1002\/art.21289","volume":"52","author":"RM Clancy","year":"2005","unstructured":"Clancy RM et al. (2005) Maternal antibody responses to the 52 kDa SSA\/Ro p200 peptide and the development of fetal conduction defects. Arthritis Rheum 52: 3079\u20133086","journal-title":"Arthritis Rheum"},{"key":"BFncprheum1018_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1191\/0961203303lu425xx","volume":"12","author":"DG Solomon","year":"2003","unstructured":"Solomon DG et al. (2003) Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling. Lupus 12: 646\u2013647","journal-title":"Lupus"},{"key":"BFncprheum1018_CR15","first-page":"2480","volume":"31","author":"P Gordon","year":"2004","unstructured":"Gordon P et al. (2004) Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheum 31: 2480\u20132487","journal-title":"J Rheum"},{"key":"BFncprheum1018_CR16","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1046\/j.1432-1033.2000.01785.x","volume":"267","author":"A Vincent","year":"2000","unstructured":"Vincent A et al. (2000) Molecular targets for autoimmune and genetic disorders of neuromuscular transmission. Eur J Biochem 267: 6717\u20136728","journal-title":"Eur J Biochem"},{"key":"BFncprheum1018_CR17","volume-title":"Infection, Resistance and Immunity","author":"JP Kreier","year":"2002","unstructured":"Kreier JP (2002) Infection, Resistance and Immunity, edn 2. Oxford, UK: Taylor & Francis"},{"key":"BFncprheum1018_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/art.1780350209","volume":"35","author":"E Alexander","year":"1992","unstructured":"Alexander E et al. (1992) Anti-Ro\/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model: in vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum 35: 176\u2013189","journal-title":"Arthritis Rheum"},{"key":"BFncprheum1018_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1172\/JCI117025","volume":"93","author":"S Garcia","year":"1994","unstructured":"Garcia S et al. (1994) Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro\/SSA-positive patients in rabbit hearts. J Clin Invest 93: 718\u2013724","journal-title":"J Clin Invest"},{"key":"BFncprheum1018_CR20","first-page":"354","volume":"80","author":"M Boutjdir","year":"1998","unstructured":"Boutjdir M et al. (1998) Serum and IgG from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model. Pediatr Res 80: 354\u2013362","journal-title":"Pediatr Res"},{"key":"BFncprheum1018_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/jaut.2002.0594","volume":"19","author":"JP Buyon","year":"2002","unstructured":"Buyon JP et al. (2002) Cardiac 5-HT4 serotoninergic receptors, 52 kD SSA\/Ro and autoimmune-associated congenital heart block. J Autoimmunity 19: 79\u201386","journal-title":"J Autoimmunity"},{"key":"BFncprheum1018_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaut.2005.04.005","volume":"25","author":"R Kamel","year":"2005","unstructured":"Kamel R et al. (2005) Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: a reassessment. J Autoimmun 25: 72\u201376","journal-title":"J Autoimmun"},{"key":"BFncprheum1018_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/art.11430","volume":"50","author":"RM Clancy","year":"2004","unstructured":"Clancy RM et al. (2004) Immunohistologic evidence supports apoptosis, IgG deposition and novel macrophage\/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 50: 173\u2013182","journal-title":"Arthritis Rheum"},{"key":"BFncprheum1018_CR24","first-page":"2413","volume":"116","author":"RM Clancy","year":"2006","unstructured":"Clancy RM et al. (2006) Impaired clearance of apoptotic cardiocytes linked to anti-SSA\/Ro-SSB\/La antibodies in pathogenesis of congenital heart block. J Clin Investigation 116: 2413\u20132422","journal-title":"J Clin Investigation"},{"key":"BFncprheum1018_CR25","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.4049\/jimmunol.169.4.2156","volume":"169","author":"RM Clancy","year":"2002","unstructured":"Clancy RM et al. (2002) Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA\/Ro-SSB\/La antibody-mediated congenital heart block. J Immunol 169: 2156\u20132163","journal-title":"J Immunol"},{"key":"BFncprheum1018_CR26","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.4049\/jimmunol.165.9.5345","volume":"165","author":"ME Miranda-Car\u00fas","year":"2000","unstructured":"Miranda-Car\u00fas ME et al. (2000) Anti-SSA\/Ro and anti-SSB\/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of tumor necrosis factor \u03b1 by macrophages. J Immunol 165: 5345\u20135351","journal-title":"J Immunol"},{"key":"BFncprheum1018_CR27","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.4049\/jimmunol.171.6.3253","volume":"171","author":"RM Clancy","year":"2003","unstructured":"Clancy RM et al. (2003) Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-\u03b1 and TGF\u03b21 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 171: 3253\u20133261","journal-title":"J Immunol"},{"key":"BFncprheum1018_CR28","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1002\/art.23061","volume":"56","author":"RM Clancy","year":"2007","unstructured":"Clancy RM et al. (2007) Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block. Arthritis Rheum 56: 4120\u20134131","journal-title":"Arthritis Rheum"},{"key":"BFncprheum1018_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/01.CIR.56.1.82","volume":"56","author":"CM McCue","year":"1977","unstructured":"McCue CM et al. (1977) Congenital heart block in newborns of mothers with connective tissue disease. Circulation 56: 82\u201390","journal-title":"Circulation"},{"key":"BFncprheum1018_CR30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0022-3476(88)80581-X","volume":"113","author":"RL Geggel","year":"1988","unstructured":"Geggel RL et al. (1988) Postnatal progression from second- to third-degree heart block in neonatal lupus syndrome. J Ped 113: 1049\u20131052","journal-title":"J Ped"},{"key":"BFncprheum1018_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1191\/0961203302lu173oa","volume":"11","author":"AD Askanase","year":"2002","unstructured":"Askanase AD et al. (2002) Spectrum and progression of conduction abnormalities in infants born to mothers with anti-Ro\/La antibodies. Lupus 11: 145\u2013151","journal-title":"Lupus"},{"key":"BFncprheum1018_CR32","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","volume":"42","author":"S Saleeb","year":"1999","unstructured":"Saleeb S et al. (1999) Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block. Arthritis Rheum 42: 2335\u20132345","journal-title":"Arthritis Rheum"},{"key":"BFncprheum1018_CR33","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","volume":"110","author":"ET Jaeggi","year":"2004","unstructured":"Jaeggi ET et al. (2004) Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110: 1542\u20131548","journal-title":"Circulation"},{"issue":"4","key":"BFncprheum1018_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0029-7844(98)00149-5","volume":"92","author":"D ROSENTHAL","year":"1998","unstructured":"Rosenthal D et al. (1998) A new therapeutic approach to the fetus with congenital complete heart block: pre-emptive, targeted therapy with dexamethasone. Obstet Gynecol 92: 689\u2013691","journal-title":"Obstetrics & Gynecology"},{"key":"BFncprheum1018_CR35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/uog.1713","volume":"24","author":"JMPJ Breur","year":"2004","unstructured":"Breur JMPJ et al. (2004) Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature. Ultrasound Obstet Gynecol 24: 467\u2013472","journal-title":"Ultrasound Obstet Gynecol"},{"key":"BFncprheum1018_CR36","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1136\/ard.2005.049866","volume":"65","author":"A Brucato","year":"2006","unstructured":"Brucato A et al. (2006) Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero. Ann Rheum Dis 65: 1422\u20131426","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum1018_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1177\/0961203306071869","volume":"15","author":"P Airo'","year":"2006","unstructured":"Airo' P et al. (2006) Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro\/SS-A antibodies associated congenital heart block. Lupus 15: 553\u2013561","journal-title":"Lupus"},{"key":"BFncprheum1018_CR38","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/art.20126","volume":"50","author":"SE Sonesson","year":"2004","unstructured":"Sonesson SE et al. (2004) Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA\/Ro 52 kD antibodies. Arthritis Rheum 50: 1253\u20131261","journal-title":"Arthritis Rheum"},{"key":"BFncprheum1018_CR39","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0002-9149(01)02130-0","volume":"88","author":"G Andelfinger","year":"2001","unstructured":"Andelfinger G et al. (2001) Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques. Am J Cardiol 88: 1433\u20131436","journal-title":"Am J Cardiol"},{"key":"BFncprheum1018_CR40","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.4049\/jimmunol.169.4.2156","volume":"169","author":"RM Clancy","year":"2002","unstructured":"Clancy RM et al. (2002) Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA\/Ro-SSB\/La antibody-mediated congenital heart block. J Immunol 169: 2156\u20132163","journal-title":"J Immunol"},{"key":"BFncprheum1018_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/art.10716","volume":"48","author":"R Kaaja","year":"2003","unstructured":"Kaaja R and Julkunen H (2003) Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al. [letter]. Arthritis Rheum 48: 281\u2013282","journal-title":"Arthritis Rheum"},{"key":"BFncprheum1018_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.beha.2005.01.032","volume":"18","author":"RJ Looney","year":"2006","unstructured":"Looney RJ and Huggins J (2006) Use of intravenous immunoglobulin (IVIG). Best Pract Res Clin Haematol 18: 3\u201325","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFncprheum1018_CR43","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1126\/science.291.5503.484","volume":"291","author":"A Samuelsson","year":"2001","unstructured":"Samuelsson A et al. (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291: 445\u2013446","journal-title":"Science"},{"key":"BFncprheum1018_CR44","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","volume":"26","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F and Ravetch JV (2008) Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 26: 513\u2013533","journal-title":"Annu Rev Immunol"},{"key":"BFncprheum1018_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1154315","volume":"320","author":"RM Anthony","year":"2008","unstructured":"Anthony RM et al. (2008) Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320: 373\u2013376","journal-title":"Science"},{"key":"BFncprheum1018_CR46","unstructured":"Preventive IVIG Therapy for Congenital Heart Block (PITCH) [ http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00460928?term=NCT00460928&rank=1 ] (accessed 13 January 2009)"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum1018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum1018","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum1018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T06:23:52Z","timestamp":1684909432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum1018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["BFncprheum1018"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum1018","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}